Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic pathways and treatment strategies without a systematic review protocol or primary clinical trial data
PubMed 41473651 · doi:10.7759/cureus.98103
What was done
This narrative review synthesized literature on the pathophysiological links between polycystic ovary syndrome (PCOS) and acne vulgaris, focusing on hyperandrogenism, insulin resistance, diagnostic frameworks (Rotterdam criteria), and evidence-based therapeutic options.
What was found
The abstract reports no numerical values, sample sizes, or quantitative effect estimates. It qualitatively describes how luteinizing hormone elevation, thecal androgen excess, and insulin resistance (which lowers sex hormone-binding globulin and increases free testosterone) drive acne. It summarizes treatment strategies including combined oral contraceptives with antiandrogenic progestins, spironolactone, metformin, standard topicals (retinoids, benzoyl peroxide), antibiotics, and oral isotretinoin for refractory disease.
Why it matters
It highlights that durable management of acne in PCOS requires addressing underlying hormonal and metabolic dysregulation in addition to standard topical dermatologic treatments.
Limits
As an unsystematic narrative review, it lacks predefined search protocols, inclusion criteria, and formal risk-of-bias assessments. The abstract presents no original empirical data or numerical outcome measurements.
Cited by
- supports In polycystic ovarian syndrome (PCOS), high insulin causes elevated androgens which leads to thinning hair on the top of the scalp.